In a second step, WifOR calculates the resulting productivity gains from both paid and unpaid work. To this end, indicators such as patient-reported outcomes (PRO) from Work Productivity and Activity Impairment (WPAI) questionnaires are used. To measure the Social Impact of a medical innovation, WifOR first quantifies the degree to which a patient is burdened by a disease and to what extent the innovation reduces the impairment. How to measure the Social Impact of medical innovations This corresponds to 22 million paid and 15 million unpaid working hours per year and a potentially avoided productivity loss of USD 728.3 million – USD 490 per patient. For one patient, this translates into 24.6 hours without any symptoms during the severe JCP symptom period of three weeks. Omalizumab has the potential to reduce paid and unpaid work productivity losses for approximately 37 million hours in an assumed population of 1.5 million patients with severe forms of Japanese cedar pollinosis (JCP). For example, an Allergic Rhinitis medication can enable chronically ill patients to continue to work and pursue their daily activities.įor instance, t he results of a study recently published by WifOR show that the humanized monoclonal anti-immunoglobulin E (IgE) antibody Omalizumab can significantly lower the corresponding disease burden of Japanese Cedar Pollinosis (JCP). The Social Impact quantifies and monetizes the productivity losses of paid and unpaid work that might be avoided due to a medical innovation (such as a drug). Through the Social Impact of medical innovations approach, WifOR measures the benefit from innovations for society in terms of health and productivity effects. Besides, the socioeconomic burden of a disease can serve as the basis to measure the social impact of a medical innovation. Socioeconomic losses include not only the time lost from paid work but also those from unpaid work such as childcare or care of relatives. In addition to prevalence and incidence, the socioeconomic burden highlights the significance of a disease for society. In an analysis of 17.2 million patients suffering severe forms of Japanese Cedar Pollinosis (JCP), WifOR identified a productivity loss of 26.1 billion US Dollars (USD) annually – an average of USD 1,522 per patient. Inadequately controlled symptoms not only limit the quality of life of those affected but also lead to major economic losses. In 2019, 38.8 percent of the entire Japanese population was affected by AR caused by Japanese cedar pollen. Itchy eyes, sneezing, and sinus pressure: Allergic Rhinitis (AR), caused by specific pollen antigens, is one of the most common chronic allergic respiratory diseases worldwide. In this article, you will learn more about the socioeconomic perspective, how WifOR calculates the Social Impact of a medical innovation, and which insights the model provides. In Social Impact studies, WifOR thus aims to shift the discussion from costs to the socioeconomic value for society. This leads to a focus on price, whereas the effects on society, the so-called “Social Impact”, are undervalued. This analysis is of crucial importance in understanding the impact of digital health care applications and provides a necessary framework for the emerging, dynamic system of e-health.What is our health worth? In public debates, a misconception tends to prevail that a high-quality healthcare system is expensive. Rather, we should ask how the underlying paradigm shift, from discovery and cure to prevention and prediction, acts as a facilitator to embrace ICT in health care. 'Will e-health cause a paradigm shift in medicine?' might not be the right question to pose. On the other hand the characteristics of e-health will be strongly determined by this new paradigm. E-health constitutes an essential part of this new paradigm that seeks to solve the challenges presented by an aging population, skyrocketing costs and so forth. This promotes the evolution towards a new paradigm in medicine with an emphasis on preventive, predictive and personalized care. Nowadays the long-standing curative paradigm in medicine is facing important challenges due to an aging population, a significant increase in chronic diseases and the development of more expensive diagnostic tools and therapies. Their work offers key insights to a comprehensive understanding of major evolutions in medicine. Many medical practitioners and scholars wonder: will e-health cause a paradigm shift in health care? To answer this question we provide a philosophical analysis of the concept of the 'paradigm shift' through the work of Michel Foucault, Thomas Kuhn and Larry Laudan. In the last two decades Information and Computer Technology has come to play an increasingly important role in medicine and health care.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |